Publication

Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation

Thornton, Tina
Pedraza-Alva, Gustavo
Deng, Bin
Wood, C. David
Aronshtam, Alexander
Clements, James L.
Sabio, Guadalupe
Davis, Roger J.
Matthews, Dwight E.
Doble, Bradley
... show 1 more
Embargo Expiration Date
Abstract

Glycogen synthase kinase 3beta (GSK3beta) is involved in metabolism, neurodegeneration, and cancer. Inhibition of GSK3beta activity is the primary mechanism that regulates this widely expressed active kinase. Although the protein kinase Akt inhibits GSK3beta by phosphorylation at the N terminus, preventing Akt-mediated phosphorylation does not affect the cell-survival pathway activated through the GSK3beta substrate beta-catenin. Here, we show that p38 mitogen-activated protein kinase (MAPK) also inactivates GSK3beta by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of beta-catenin. p38 MAPK-mediated phosphorylation of GSK3beta occurs primarily in the brain and thymocytes. Activation of beta-catenin-mediated signaling through GSK3beta inhibition provides a potential mechanism for p38 MAPK-mediated survival in specific tissues.

Source

Science. 2008 May 2;320(5876):667-70. doi: 10.1126/science.1156037. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1126/science.1156037
PubMed ID
18451303
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License